Table 2.
Baseline patient characteristics
| Characteristic | TH group (N = 69) | SOC group (N = 69) | p value |
|---|---|---|---|
| Age, years (mean±SDa) | 52.3 ± 10.6 | 50.0 ± 11.7 | 0.23 |
| Male sex, n (%) | 50/69 (72.5) | 45/69 (65.2) | 0.36 |
| Body mass index, kg/m2 (mean ± SD) | 33.5 ± 8.2 | 32.9 ± 7.1 | 0.63 |
| Ethnicity, n (%) | (68) | (61) | |
| Caucasian | 49/68 (72.1) | 50/61 (82.0) | 0.34 |
| Hispanic | 11/68 (16.2) | 4/61 (6.6) | |
| African-American | 3/68 (4.4) | 2/61 (3.3) | |
| Asian | 5/68 (7.4) | 4/61 (6.6) | |
| Other | 0 (0) | 1/61 (1.6) | |
| ESSb score | (n = 66) | (n = 68) | |
| Mean ± SD | 10.9 ± 4.7 | 10.2 ± 5.7 | 0.42 |
| Median | 11.0 | 10.0 | |
| AHIc/h | (n = 69) | (n = 69) | |
| Mean ± SD | 33.4 ± 24.5 | 27.4 ± 18.0 | 0.23 |
| Median | 27.2 | 23.2 | |
| PAP device, n (%) | |||
| S9 Elite | 59/69 (85.5) | 58/69 (84.1) | 0.81 |
| AutoSet | 10/69 (14.5) | 11/69 (15.9) | |
| Mask type, n (%) | |||
| FFMd | 20/68 (29.4) | 20/69 (29.0) | 0.90 |
| Nasal mask | 39/68 (57.4) | 38/69 (55.1) | |
| Nasal pillow | 9/68 (13.2) | 11/69 (15.9) | |
| Device therapy setting, cmH2O | (n = 58) | (n = 58) | |
| Mean ± SD (n) | 10.6 ± 2.5 | 10.5 ± 2.0 | 0.81 |
| Median | 10.0 | 10.0 |
aStandard deviation
bEpworth Sleepiness Scale
cApnea-hypopnea index
dFull face mask